AAAAAA

   
Results: 1-10 |
Results: 10
REQUIREMENT OF RAS-GTP-RAF COMPLEXES FOR ACTIVATION OF RAF-1 BY PROTEIN-KINASE-C
Authors: MARAIS R LIGHT Y MASON C PATERSON H OLSON MF MARSHALL CJ
Citation: R. Marais et al., REQUIREMENT OF RAS-GTP-RAF COMPLEXES FOR ACTIVATION OF RAF-1 BY PROTEIN-KINASE-C, Science, 280(5360), 1998, pp. 109-112
A CELL-SURFACE TETHERED ENZYME IMPROVES EFFICIENCY IN GENE-DIRECTED ENZYME PRODRUG THERAPY
Authors: MARAIS R SPOONER RA STRIBBLING SM LIGHT Y MARTIN J SPRINGER CJ
Citation: R. Marais et al., A CELL-SURFACE TETHERED ENZYME IMPROVES EFFICIENCY IN GENE-DIRECTED ENZYME PRODRUG THERAPY, Nature biotechnology, 15(13), 1997, pp. 1373-1377
NEW ENZYME PRODRUG COMBINATIONS FOR USE IN GENE-DIRECTED ENZYME PRODRUG THERAPY (GDEPT)/
Authors: SPRINGER CJ SPOONER RA FRIEDLOS F MARTIN J STRIBBLING S DAVIES L NICULESCUDUVAZ D NICULESCUDUVAZ I MAYCROFT K LIGHT Y MARAIS R
Citation: Cj. Springer et al., NEW ENZYME PRODRUG COMBINATIONS FOR USE IN GENE-DIRECTED ENZYME PRODRUG THERAPY (GDEPT)/, Cancer gene therapy, 4(6), 1997, pp. 106-106
DIFFERENTIAL REGULATION OF RAF-1, A-RAF, AND B-RAF BY ONCOGENIC RAS AND TYROSINE KINASES
Authors: MARAIS R LIGHT Y PATERSON HF MASON CS MARSHALL CJ
Citation: R. Marais et al., DIFFERENTIAL REGULATION OF RAF-1, A-RAF, AND B-RAF BY ONCOGENIC RAS AND TYROSINE KINASES, The Journal of biological chemistry, 272(7), 1997, pp. 4378-4383
RADIOACTIVE LABELING OF RECOMBINANT ANTIBODY FRAGMENTS BY PHOSPHORYLATION USING HUMAN CASEIN KINASE-II AND [GAMMA-P-32]-ATP
Authors: NERI D PETRUL H WINTER G LIGHT Y MARAIS R BRITTON KE CREIGHTON AM
Citation: D. Neri et al., RADIOACTIVE LABELING OF RECOMBINANT ANTIBODY FRAGMENTS BY PHOSPHORYLATION USING HUMAN CASEIN KINASE-II AND [GAMMA-P-32]-ATP, Nature biotechnology, 14(4), 1996, pp. 485-490
CELL-CYCLE REGULATION OF B-MYB PROTEIN EXPRESSION - SPECIFIC PHOSPHORYLATION DURING THE S-PHASE OF THE CELL-CYCLE
Authors: ROBINSON C LIGHT Y GROVES R MANN D MARAIS R WATSON R
Citation: C. Robinson et al., CELL-CYCLE REGULATION OF B-MYB PROTEIN EXPRESSION - SPECIFIC PHOSPHORYLATION DURING THE S-PHASE OF THE CELL-CYCLE, Oncogene, 12(9), 1996, pp. 1855-1864
GDEPT (GENE-DIRECTED ENZYME PRODRUG THERAPY) WITH THE CARBOXYPEPTIDASE G2 ENZYME IN COMBINATION WITH A MUSTARD PRODRUG
Authors: MARAIS R SPOONER RA LIGHT Y MARTIN J SPRINGER CJ
Citation: R. Marais et al., GDEPT (GENE-DIRECTED ENZYME PRODRUG THERAPY) WITH THE CARBOXYPEPTIDASE G2 ENZYME IN COMBINATION WITH A MUSTARD PRODRUG, Cancer gene therapy, 3(6), 1996, pp. 79-79
IMPORTANCE OF LOW-AFFINITY ELF-1 SITES IN THE REGULATION OF LYMPHOID-SPECIFIC INDUCIBLE GENE-EXPRESSION
Authors: JOHN S MARAIS R CHILD R LIGHT Y LEONARD WJ
Citation: S. John et al., IMPORTANCE OF LOW-AFFINITY ELF-1 SITES IN THE REGULATION OF LYMPHOID-SPECIFIC INDUCIBLE GENE-EXPRESSION, The Journal of experimental medicine, 183(3), 1996, pp. 743-750
GENE-DIRECTED ENZYME PRODRUG THERAPY WITH A MUSTARD PRODRUG CARBOXYPEPTIDASE G2 COMBINATION/
Authors: MARAIS R SPOONER RA LIGHT Y MARTIN J SPRINGER CJ
Citation: R. Marais et al., GENE-DIRECTED ENZYME PRODRUG THERAPY WITH A MUSTARD PRODRUG CARBOXYPEPTIDASE G2 COMBINATION/, Cancer research, 56(20), 1996, pp. 4735-4742
RAS RECRUITS RAF-1 TO THE PLASMA-MEMBRANE FOR ACTIVATION BY TYROSINE PHOSPHORYLATION
Authors: MARAIS R LIGHT Y PATERSON HF MARSHALL CJ
Citation: R. Marais et al., RAS RECRUITS RAF-1 TO THE PLASMA-MEMBRANE FOR ACTIVATION BY TYROSINE PHOSPHORYLATION, EMBO journal, 14(13), 1995, pp. 3136-3145
Risultati: 1-10 |